They were significantly associated with ESR, CRP, and DAS28-ESR scores, and lnc-NEAT1 expression levels were significantly decreased in remission compared with non-remission patients; these biomarkers might indicate RA treatment efficacy and disease activity (163). The gene discussed is NEAT1; the disease is rheumatoid arthritis.